Alexion Pharmaceuticals, Inc. (ALXN) financial statements (2020 and earlier)

Company profile

Business Address 121 SEAPORT BOULEVARD
BOSTON, MA 02210
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments2,7501,5641,4741,2931,3851,962
Cash and cash equivalents2,6861,3665849661,010944
Short-term investments641988903273751,018
Receivables1,243922727650533433
Inventory, net of allowances, customer advances and progress billings628473460375290176
Inventory628473460375290176
Other current assets456426293260218189
Other undisclosed current assets     36
Total current assets:5,0763,3852,9542,5782,4252,796
Noncurrent Assets
Property, plant and equipment1,1631,4721,3251,036697392
Intangible assets, net (including goodwill)8,3828,6798,9929,3409,756841
Goodwill5,0375,0375,0375,0375,048254
Intangible assets, net (excluding goodwill)3,3443,6413,9544,3034,708587
Restricted cash and investments0     
Other noncurrent assets429397312299255138
Other undisclosed noncurrent assets2,494    35
Total noncurrent assets:12,46810,54710,62910,67510,7081,406
TOTAL ASSETS:17,54513,93213,58313,25313,1334,202
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:967698710572461623
Accounts payable  71645744
Accrued liabilities201171639508403395
Employee-related liabilities191170   88
Taxes payable10424   95
Other undisclosed accounts payable and accrued liabilities471332    
Debt1279416716717548
Restructuring reserve 4    
Business combination, contingent consideration, liability 98 24  
Deferred revenue and credits16372159
Contract with customer, liability3
Other liabilities1013459236261
Other undisclosed current liabilities 242   (183)
Total current liabilities:1,1941,174953823718607
Noncurrent Liabilities
Long-term debt and lease obligation2,3752,5022,7212,8883,28110
Long-term debt, excluding current maturities2,3752,5022,7212,8883,28110
Liabilities, other than long-term debt29317315911062684
Deferred tax liabilities, net   5297
Liability, pension and other postretirement and postemployment benefits281819202324
Other liabilities266156140907353
Other undisclosed noncurrent liabilities2,410918858738249200
Total noncurrent liabilities:5,0793,5933,7383,7364,156293
Total liabilities:6,2734,7674,6904,5594,875900
Stockholders' equity
Stockholders' equity attributable to parent11,2729,1658,8938,6948,2593,302
Common stock    00
Treasury stock, value(2,106)(1,690)(1,605)(1,141)(711)(383)
Additional paid in capital8,8058,5398,2907,9577,7272,592
Accumulated other comprehensive income (loss)(67)(10)(34)606257
Retained earnings4,6402,3262,2421,8181,1801,036
Total stockholders' equity:11,2729,1658,8938,6948,2593,302
TOTAL LIABILITIES AND EQUITY:17,54513,93213,58313,25313,1334,202

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues4,9914,1313,5513,0822,6032,234
Revenue, net3,5513,0842,6042,234
Cost of revenue
(Cost of Goods and Services Sold)
(395)(374)(454)(258)(233)(174)
Gross profit:4,5973,7573,0972,8242,3692,060
Operating expenses(2,476)(3,487)(2,470)(2,159)(1,834)(1,191)
Other undisclosed operating income   22 
Operating income:2,120270627667537869
Nonoperating income1367119696
Investment income, nonoperating10065191198
Foreign currency transaction gain (loss), before tax  0(5)1(2)
Other nonoperating income366    
Interest and debt expense(78)(98)(98)(97)(48)(3)
Income from continuing operations before income taxes:2,179242548576498872
Income tax expense (benefit)226(165)(105)(177)(354)(215)
Net income available to common stockholders, diluted:2,40478443399144657

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net income:2,40478443399144657
Other comprehensive income (loss)10(7)2 32
Comprehensive income:2,41571445399147659
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(67)32(97)(2)278
Comprehensive income, net of tax, attributable to parent:2,347102348397150737

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: